Journals / Turkish Journal of Veterinary and Animal Sciences / 2020 / Cilt: 44 - Sayı: 2

The investigation of the possible antigenotoxic in vivo effects of pomegranate (Punica granatum L.) peel extract on mitomycin-C genotoxicity

Pages
382–390
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As a result, it was determined that the peel extract at the stated dose showedantigenotoxic effects against the genotoxicity caused by mitomycin-C in the bone marrow cells of mice.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of this study was to investigate the possible antigenotoxic effects of the extract of pomegranate (Punica granatumL.) peel, which has high antioxidant activity against the genotoxic effects that mitomycin-C creates in the bone marrow cells of mice bya chromosomal aberration, mitotic activity, and micronucleus test system.
📊
Key Findings & Data:There were six groups including a negative control group,positive control group (2 mg/kg mitomycin-C (MMC)), 150 mg/kg P. granatum L. (PG) peel extract, 300 mg/kg PG peel extract, 150 mg/kg PG + MMC, and 300 mg/kg PG + MMC.
💡
Conclusion & Impact:As a result, it was determined that the peel extract at the stated dose showedantigenotoxic effects against the genotoxicity caused by mitomycin-C in the bone marrow cells of mice.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The aim of this study was to investigate the possible antigenotoxic effects of the extract of pomegranate (Punica granatumL.) peel, which has high antioxidant activity against the genotoxic effects that mitomycin-C creates in the bone marrow cells of mice bya chromosomal aberration, mitotic activity, and micronucleus test system. There were six groups including a negative control group,positive control group (2 mg/kg mitomycin-C (MMC)), 150 mg/kg P. granatum L. (PG) peel extract, 300 mg/kg PG peel extract, 150 mg/kg PG + MMC, and 300 mg/kg PG + MMC. The extract of pomegranate peel was given to mice by oral gavage for 15 days. At the endof day 15, 2 mg/kg MMC was intraperitoneally administered to the mice. Chromosomal aberration, mitotic activity, and micronucleusrates were determined in bone marrow cells of the mice, which were euthanized 24 h after this application. As a result of the observationscarried out, it was determined that the chromosomal aberrations and micronucleus ratios in the MMC group were at the maximumlevel in terms of chromosomal aberration rates and micronucleated polychromatic erythrocytes; this rate decreased with 150 mg/kg PGand 300 mg/kg PG peel extract application with MMC, and PG peel extract applied with MMC significantly increased this decreasedue to dose increase (P < 0.001). It was observed that MMC application decreased mitotic activity and polychromatic erythrocyte/normochromatic erythrocyte ratios, while statistically these rates significantly increased in the groups administered peel extract withMMC when compared to the MMC group (P < 0.001). As a result, it was determined that the peel extract at the stated dose showedantigenotoxic effects against the genotoxicity caused by mitomycin-C in the bone marrow cells of mice.

🔖

Cite This Article

ULUMAN, E., KILIÇLE, P. A. (2022). The investigation of the possible antigenotoxic in vivo effects of pomegranate (Punica granatum L.) peel extract on mitomycin-C genotoxicity. Turkish Journal of Veterinary and Animal Sciences, Cilt: 44 - Sayı: 2, 382–390. https://ajindex.com/articles/614765

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Gracious Ross R, Selvasubramanian S, Jayasundar S. Inmunomodulatory activity of Punica granatum in rabbits: a preliminary study. Journal of Ethnopharmacology 2001; 78 (1): 85-87. doi: 10.1016/s0378-8741(01)00287-2 2. Murthy KN, Reddy VK, Veigas JM, Murthy UD. Study on wound healing activity of Punica granatum peel. Journal of Medicinal Food 2004; 7 (2): 256-259. doi: 10.1089/1096620041224111 3. Jurenka J. Therapeutic applications of pomegranate (Punica granatum L.) a review. Alternative Medicine Review 2008; 13 (2): 128-144. 4. Singh RP, Chidambara Murthy KN, Jayaprakasha GK. Studies on the antioxidant activity of pomegranate (Punica granatum) peel and seed extracts using in vitro models. Journal Agricultural Food Chemistry 2002; 50 (1): 81-86. doi: 10.1021/ jf010865b 5. Shams Ardekani MR, Hajimahmoodi M, Oveisi MR, Sadeghi N, Jannat B et al. Comparative antioxidant activity and total flavonoid content of Persian pomegranate (Punica granatum L.) cultivars. Iranian Journal of Pharmaceutical Research 2011; 10 (3): 519-524. doi: 10.22037/IJPR.2011.948 6. Lansky EP, Newman RA. Punica granatum (pomegranate) and its potential for prevention and treatment of ınflammation and cancer. Journal of Ethnopharmacology 2007; 109 (2): 177-206. doi: 10.1016/j.jep.2006.09.006 7. Ben Nasr C, Ayed N, Metche M. Quantitative determination of the polyphenolic content of pomegranate peel. Zeitschrift Lebensittel Unters Forsch 1996; 203 (4): 374-378. doi: 10.1007/ bf01231077 8. Prashanth D, Asha MK, Amit A. Antibacterial activity of Punica granatum. Fitoterapia 2001; 72 (2): 171-173. doi: 10.1016/S0367-326X(00)00270-7 9. Braga LC, Leite AA, Xavier KG, Takahashi JA, Bemquerer MP et al. Synergic interaction between pomegranate extract and antibiotics against Staphylococcus aureus. Canadian Journal of Microbiology 2005; 51 (7): 541-547. doi: 10.1139/w05-022 10. Menezes SM, Cordeiro LN, Viana GS. Punica granatum (pomegranate) extract is active against dental plaque. Journal of Herbal Pharmacotherapy 2006; 6 (2): 79-92. 11. Vasconcelos LC, Sampaio FC, Sampaio MC, Pereira MS, Higino JS et al. Minimum inhibitory concentration of adherence of Punica granatum Linn (pomegranate) gel against S. mutans, S. mitis and C. albicans. Brazilian Dental Journal 2006; 17 (3): 223-227. doi: 10.1590/S0103-64402006000300009 12. Aqil F, Ahmad I. Antibacterial properties of traditionally used Indian medicinal plants. Methods and findings in experimental and clinical. Pharmacology 2007; 29 (2): 79-92. do